Abdulfattah salah Fararjeh
Taipei Medical University, Taiwan
Dr. Fararjeh has his expertise in molecular biology and human genetic. He is doing his PhD in cancer biology and drug discovery with focusing on the molecular basis of breast cancer. He recently published one review paper in 2016 and another is original research in human pathology 2018. In addition, he has been submitted another in environmental toxicology journal. Dr. Fararjeh devote his time for research.
Abstract : Long-term exposure to extremely low-dose of nicotine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induce non-malignant breast epithelial cell transformation through activation of the a9-nicotinic acetylcholine receptor-mediated signaling pathway